Cdc2L5 (ZZ08) Antibody sc-81837 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemCdc2L5 (ZZ08) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $333.00Supplier Page View Company Product Page
Catalog Numbersc-81837
NCBI Gene AliasesCdc2l5, 2310015O17Rik, hCDK13, CDC2L5, CHED, CDC2L, CHDFIDD
Antibody TypePrimary Antibodies
Quantity100 µg/ml
CloneZZ08
ApplicationsWB, IP, IF, ELISA
Reactivitymouse, rat, human
Hostmouse
Conjugate/TagUnconjugated
ClonalityMonoclonal
FormatPurified
NCBI Full Gene Namecyclin dependent kinase 13
TargetCdc2L5
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibitionEMBO ReportsApril 28, 2025Céline Moison, Rodrigo Mendoza-Sanchez, Deanne Gracias, Doris A Schuetz, Jean-François Spinella, Simon Girard, Bounkham Thavonekham, Jalila Chagraoui, Aurélie Durand, Simon Fortier, et al.,Santa Cruz Biotechnology,sc-376371 CDK12,Cell Signaling Technology,11973S CDK13,Santa Cruz Biotechnology,sc-81837 RNA polymerase II phospho-serine2,Abcam,ab5095 DDB1,Cell Signaling Technology,5428S c-MYC,Abcam,ab32072 MCL1,Cell Signaling Technology

(2) 3-Deoxysappanchalcone Inhibits Cell Growth of Gefitinib-Resistant Lung Cancer Cells by Simultaneous Targeting of EGFR and MET KinasesBiomolecules & therapeuticsJuly 1, 2023Lee JY, Lee SO, Kwak AW, Chae SB, Cho SS, Yoon G, Kim KT, Choi YH, Lee MH, Joo SH, et al.

(3) Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and CDK13 interactionJournal of thoracic diseaseApril 28, 2023Jiang J, Yu W, Fang T, Li Y, Liang J, Zhao R, Feng Z, Wang J, Tian H.Cat#52894), antibody against beta Actin (Invitrogen Cat#MA1-140), antibody against CDK13 (Santa Cruz Cat#sc-81837), antibody against P-EGFR (Cell Signaling Cat#2236), antibody against p-HER2 (Cell Signaling Cat#2243),

(4) Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signalingScience advancesJanuary 20, 2023Chen S, Shao F, Zeng J, Guo S, Wang L, Sun H, Lei JH, Lyu X, Gao S, Chen Q, et al.catalog no. 4820 or 9191; Cell Signaling Technology, Danvers, MA), anti-CDC2L5 (1:200; catalog no. sc-81837; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti–β-actin (1:5000; catalog no. A2228; Sigma-Aldrich,

Be the First to Write a Review!

Cdc2L5 (ZZ08) Antibody

Cdc2L5 (ZZ08) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (4)

Reviews

Cdc2L5 (ZZ08) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map